Tag: ACAD stock

Analysts Viewpoint

Deutsche Bank analysts upgrades a Buy rating for Acadia Pharmaceuticals Inc (ACAD)

Acadia Pharmaceuticals Inc’s recently made public that its PRINCIPAL ACCOUNTING OFFICER Kihara James unloaded Company’s shares for reported $90000.0 on

Stock Earnings

Acadia Pharmaceuticals Inc [ACAD] PRINCIPAL ACCOUNTING OFFICER makes an insider purchase of 4,000 shares worth 90000.0.

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Selling Buzz: Acadia Pharmaceuticals Inc [ACAD] PRINCIPAL ACCOUNTING OFFICER Kihara James sells 4,000 shares of the company

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Insiders Updates

Analyzing Acadia Pharmaceuticals Inc (ACAD) After Recent Trading Activity

In a filing, Acadia Pharmaceuticals Inc revealed its PRINCIPAL ACCOUNTING OFFICER Kihara James unloaded Company’s shares for reported $19374.0 on